BioSpace News Archive

Business

F-star Appoints Darlene Deptula-Hicks as Chief Financial Officer and Opens Office in Cambridge, MA

F-star Therapeutics Ltd. announces the appointment of Darlene Deptula-Hicks, MBA as Chief Financial Officer, succeeding Tolga Hassan, who is appointed to serve as F-star’s Chief Operating Officer.

June 18, 2019
·
3 min read
Policy

Atox Bio Announces Exercise by BARDA of Next Option Period to Support Continued Development of Reltecimod for NSTI

Atox Bio announced the Biomedical Advanced Research and Development Authority has exercised the next option on a performance-based contract with for the development of Reltecimod in patients with Necrotizing Soft Tissue Infections.

June 18, 2019
·
4 min read
Pharm Country

Cellular Biomedicine Group Executives to Present at CAR-TCR Summit Asia

Cellular Biomedicine Group Inc. announced that several of its executives will participate in the upcoming CAR-TCR Summit Asia to be held in Shanghai, June 19-20, 2019.

June 18, 2019
·
3 min read
Business

Kleo Pharmaceuticals Announces a CD38 Targeting Antibody Recruiting Molecule (ARM™) to Treat Multiple Myeloma as the First Clinical Candidate in its Partnership with PeptiDream

Kleo Pharmaceuticals, Inc. announced that CD38-ARM, a CD38 targeting antibody recruiting molecule to treat multiple myeloma, will be its first product candidate to move into the clinic with anticipated human studies to commence in 2020.

June 18, 2019
·
4 min read
Deals

Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Test

Test will enable fast quarantine of those infected with the most virulent and detrimental strains

June 18, 2019
·
3 min read
Deals

Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners

Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases

June 18, 2019
·
5 min read
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market worth USD 236.46 Million, at 7% CAGR During 2019-2023 | Technavio

According to Technavio Research Report “Human Immunodeficiency Virus Rapid Test Kits Market by end-user, and geographic regions is witnessed to grow USD 236.46 million, at a CAGR of 7% from 2019 to 2023”.

June 18, 2019
·
4 min read
Policy

Breakthrough Device Designation received from the FDA

Accelerated regulatory pathway for first internal use product

June 18, 2019
·
4 min read
Drug Development

Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology

This trial focused on so-called non-responders to hepatitis B vaccination

June 18, 2019
·
2 min read
Drug Development

Aclaris Therapeutics Announces Positive 6-Month Results from a Phase 2 Open-Label Clinical Trial of ATI-502 Topical in Patients with Androgenetic Alopecia (Male/Female Pattern-Baldness)

The trial evaluated ATI-502 in women and men with AGA. Subjects aged 18-50 years applied ATI-502 to their scalp twice daily for 26 weeks.

June 18, 2019
·
6 min read